Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21 | $5 | $56 | $85 |
| Short-Term Investments | $120 | $46 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $5 | $3 | $4 |
| Total Curr. Assets | $144 | $56 | $60 | $88 |
| Property Plant & Equip (Net) | $1 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $49 |
| Intangibles | $32 | $32 | $32 | $32 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $34 | $33 | $33 | $82 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $177 | $89 | $93 | $171 |
| Liabilities | – | – | – | – |
| Payables | $6 | $1 | $2 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $3 | $4 | $2 |
| Total Curr. Liab. | $12 | $4 | $6 | $4 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $2 | $0 | $2 |
| Other NC Liab. | $45 | $76 | $2 | $0 |
| Total NC Liab. | $48 | $78 | $2 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $1 | $1 |
| Total Liabilities | $59 | $82 | $9 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $56 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$356 | -$319 | -$203 | -$115 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $418 | $327 | $287 | $279 |
| Total Equity | $118 | $7 | $84 | $164 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $177 | $89 | $93 | $171 |
| Net Debt | -$20 | -$4 | -$56 | -$84 |